Code

Description

Unit

USP-1118394

Chloroquine Related Compound G (15 mg) (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate)

15 mg

USP-1118361

Chloroquine Related Compound E (15 mg) (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate)

15 mg

USP-1097192

Cefadroxil Related Compound I (25 mg) ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)

25 mg

USP-1097148

Cefadroxil Related Compound D (25 mg) ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)

25 mg

USP-1097126

Cefadroxil Related Compound B (25 mg) ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)

25 mg

USP-1096994

Cefadroxil System Suitability Mixture (25 mg)

25 mg

USP-1090150

Canola Oil (1 g)

1 g

USP-1086957

Calcium Lignosulfonate (40-65) (2 g)

2 g

USP-1084995

Caffeic Acid (15 mg)

15 mg

USP-1082628

Butyl Heptanoate (5 x 0.5 mL)

5 x 0,5 ml